Moderna COVID-19 Vaccine
Children ages 6 months–5 years: Should receive a 2-dose primary series separated by 4–8 weeks. Currently, a booster dose using any COVID-19 vaccine is not authorized for children in this age group who receive a Moderna primary series.
Children ages 6–11 years: Should receive a 2-dose primary series separated by 4–8 weeks. Currently, a booster dose using any COVID-19 vaccine is not authorized for children in this age group who receive a Moderna primary series.
Pfizer-BioNTech COVID-19 Vaccine
Children ages 6 months–4 years: Should receive a 3-dose primary series. The first and second doses are separated by 3–8 weeks and the second and third doses are separated by at least 8 weeks. Currently, a booster dose using any COVID-19 vaccine is not authorized for children in this age group who receive a Pfizer-BioNTech primary series.
Children ages 5–11 years: Should receive a 2-dose primary series separated by 3–8 weeks and 1 booster dose at least 5 months after completion of the primary series.
